Related Experiment Videos
[Lipid abnormalities in elderly patients with subclinical hyperthyroidism]
Zorica Caparević1, Dragos Stojanović, Vesna Ilić
1Klinika za internu medicinu, KBC Dr Dragisa Misovic-Dedinje, Beograd.
Medicinski Pregled
|April 15, 2004
Summary
Subclinical hyperthyroidism in the elderly, often presenting with cardiac issues, is linked to low cholesterol. Treatment with antithyroid drugs normalizes lipid levels and prevents complications.
Area of Science:
- Endocrinology
- Cardiology
- Lipidology
Context:
- Subclinical hyperthyroidism, defined by suppressed TSH with normal thyroid hormones, is common in elderly patients.
- It is often diagnosed late due to cardiac manifestations like atrial fibrillation and hypertrophy.
- Thyroid hormone excess can impact lipid profiles, necessitating careful monitoring.
Purpose:
- To investigate lipid abnormalities in elderly patients with subclinical hyperthyroidism.
- To evaluate the effect of antithyroid drug therapy on lipid levels.
- To highlight the importance of TSH measurement in diagnosing and managing this condition.
Summary:
- This study examined 55 elderly patients with subclinical hyperthyroidism, assessing their lipid profiles and response to methimazole treatment.
- Pre-treatment lipid levels (cholesterol, LDL, HDL) were found to be decreased.
- Post-treatment, significant increases in serum cholesterol, LDL-cholesterol, and HDL-cholesterol were observed.
Impact:
- Subclinical hyperthyroidism requires prompt diagnosis and treatment to mitigate cardiovascular risks and bone loss.
- Accurate TSH measurement is crucial for identifying subclinical hyperthyroidism, especially in elderly patients with cardiac symptoms.
- Therapeutic intervention with antithyroid drugs can restore normal lipid levels and improve patient outcomes.